跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,402 条关于
“anti-LRP4”
全部
19,402
临床试验
9,779
药物
3,708
机构
78
资讯
5,837
去年
VYVGART Achieves Primary Endpoint in Phase 3 Trial for AChR-Ab Seronegative Myasthenia Gravis
去年
Nipocalimab Receives FDA Priority Review for Generalized Myasthenia Gravis Treatment
去年
Myasthenia Gravis Market Set to Reach $10.3 Billion by 2034 Driven by Seven Late-Stage Pipeline Therapies
10个月前
Johnson & Johnson Launches First Head-to-Head FcRn Blocker Study in Myasthenia Gravis
去年
Shark-Derived VNARs Show Promise in Targeting CD20 for Lymphoma Therapy
2年前
Nipocalimab Shows Sustained Disease Control in Adolescents with Generalized Myasthenia Gravis
去年
Ipilimumab and Nivolumab Show Promise in Treating Rare Desmoid Tumors
去年
Anti-CXCR4 and Anti-PD-1 Combination Shows Promise in Liver Cancer Treatment
9天前
Rentosertib Shifts Six Proteomic Aging Clocks in Phase 2a IPF Substudy, but Cannot Separate Anti-Aging From Anti-Fibrotic Effects
去年
Lasofoxifene Enhances Immunotherapy Efficacy by Promoting Antitumor Activity
第 1 页,共 584 页
上一页
下一页